Steigerwald Gordon & Koch’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $598K | Buy |
4,655
+218
| +5% | +$25.5K | 0.06% | 81 |
|
|
2026
Q1 | $534K | Sell |
4,437
-125
| -3% | -$14.4K | 0.05% | 84 |
|
|
2025
Q4 | $480K | Sell |
4,562
-281
| -6% | -$26.4K | 0.05% | 92 |
|
|
2025
Q3 | $406K | Buy |
4,843
+6
| +0.1% | +$494 | 0.04% | 97 |
|
|
2025
Q2 | $383K | Sell |
4,837
-1,038
| -18% | -$82.5K | 0.04% | 90 |
|
|
2025
Q1 | $527K | Buy |
5,875
+63
| +1% | +$5.88K | 0.06% | 80 |
|
|
2024
Q4 | $578K | Sell |
5,812
-17
| -0.3% | -$1.75K | 0.07% | 80 |
|
|
2024
Q3 | $662K | Buy |
5,829
+643
| +12% | +$76.4K | 0.07% | 76 |
|
|
2024
Q2 | $642K | Buy |
5,186
+140
| +3% | +$18K | 0.08% | 74 |
|
|
2024
Q1 | $666K | Buy |
5,046
+69
| +1% | +$8.51K | 0.08% | 75 |
|
|
2023
Q4 | $543K | Sell |
4,977
-1,117
| -18% | -$116K | 0.07% | 79 |
|
|
2023
Q3 | $627K | Buy |
6,094
+283
| +5% | +$30.5K | 0.1% | 68 |
|
|
2023
Q2 | $671K | Buy |
5,811
+299
| +5% | +$33.9K | 0.1% | 67 |
|
|
2023
Q1 | $586K | Buy |
5,512
+183
| +3% | +$19.8K | 0.09% | 72 |
|
|
2022
Q4 | $591K | Buy |
5,329
+323
| +6% | +$33K | 0.09% | 69 |
|
|
2022
Q3 | $431K | Buy |
5,006
+17
| +0.3% | +$1.52K | 0.08% | 76 |
|
|
2022
Q2 | $455K | Buy |
4,989
+823
| +20% | +$73K | 0.08% | 78 |
|
|
2022
Q1 | $342K | Buy |
4,166
+71
| +2% | +$5.6K | 0.05% | 90 |
|
|
2021
Q4 | $314K | Sell |
4,095
-227
| -5% | -$18.1K | 0.05% | 89 |
|
|
2021
Q3 | $325K | Buy |
4,322
+76
| +2% | +$5.78K | 0.05% | 90 |
|
|
2021
Q2 | $330K | Sell |
4,246
-253
| -6% | -$18.8K | 0.05% | 88 |
|
|
2021
Q1 | $331K | Buy |
4,499
+157
| +4% | +$11.6K | 0.06% | 86 |
|
|
2020
Q4 | $339K | Buy |
4,342
+826
| +23% | +$63.2K | 0.07% | 82 |
|
|
2020
Q3 | $278K | Sell |
3,516
-51
| -1% | -$4K | 0.07% | 84 |
|
|
2020
Q2 | $263K | Buy |
3,567
+171
| +5% | +$12.9K | 0.07% | 80 |
|
|
2020
Q1 | $249K | Sell |
3,396
-77
| -2% | -$6.05K | 0.08% | 75 |
|
|
2019
Q4 | $301K | Buy |
3,473
+680
| +24% | +$55.9K | 0.07% | 77 |
|
|
2019
Q3 | $224K | Buy |
2,793
+1
| +0% | +$80 | 0.06% | 79 |
|
|
2019
Q2 | $223K | Buy |
+2,792
| New | +$214K | 0.06% | 77 |
|
|
2017
Q3 | – | Sell |
-3,703
| Closed | -$226K | – | 91 |
|
|
2017
Q2 | $226K | Buy |
+3,703
| New | +$225K | 0.06% | 79 |
|
Other funds holding MRK
Steigerwald Gordon & Koch's MRK Position: Q2 2026 in Review
Steigerwald Gordon & Koch increased its Merck (MRK) stake by 4.9% in Q2 2026, buying an estimated $25.5K and bringing the position to 4,655 shares worth $598K. The position accounts for 0.06% of the portfolio, ranked #81.
Steigerwald Gordon & Koch first reported a position in MRK in Q2 2017 and has held it in 30 quarters since. The position peaked at $671K in Q2 2023. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Steigerwald Gordon & Koch held 4,655 shares of Merck worth $598K as of Q2 2026.
- Steigerwald Gordon & Koch bought 218 Merck shares in Q2 2026, an estimated $25.5K.
- Merck made up 0.06% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #81 holding.
- Steigerwald Gordon & Koch first reported a position in Merck in Q2 2017 and has held it in 30 quarters since.
- Steigerwald Gordon & Koch's Merck position peaked at $671K in Q2 2023.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.